Press release
Cancer Biomarkers Market Rise at a CAGR of 12.5% With Key Players Abbott, DiagnoCure, Affymetrix, Illumina, QIAGEN, F. Hoffmann-La Roche, Agilent Technologies, Quest Diagnostics, Merck & Co, Hologic, BD
Global Cancer Biomarkers Market
This Cancer Biomarkers Market report encompasses an endless knowledge and information on what the market’s definition, classifications, applications, and engagements are and also explains the drivers and restraints of the market which is derived from SWOT analysis. Market segmentation study covers research and analysis which is based on numerous market and industry segments such as application, vertical, deployment model, end user, and geography. The important aspects of this market report are key market dynamics, current market scenario and future prospects of the sector. Businesses can surely anticipate the reduced risk of failure with this Cancer Biomarkers Market research report.
Request for a Free Sample Copy of this Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-cancer-biomarkers-market
Market Analysis: Global Cancer Biomarkers Market
Global Cancer Biomarkers Market is expected to rise from its initial estimated value of USD 21.85 billion in 2018 to an estimated value of USD 56.06 billion by 2026, registering a CAGR of 12.5% in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing Use of Cancer Biomarkers in Drug Discovery and Development.
Key Market Competitors: Global Cancer Biomarkers Market
Few of the major competitors currently working in the Cancer Biomarkers market are
• Abbott (U.S),
• DiagnoCure Inc ( Canada).,
• Affymetrix, Inc. (U.S),
• Illumina, Inc.(U.S.),
• QIAGEN (Germany),
• F. Hoffmann-La Roche Ltd. (Switzerland),
• Agilent Technologies Inc. (U.S.),
• Quest Diagnostics Inc. (U.S.),
• Merck & Co. Inc. (U.S.),
• Hologic, Inc ( U.S),
• BD (U.S.),
• GlaxoSmithKline plc (UK),
• Novartis AG (Switzerland),
• Bristol-Myers Squibb (US),
• Eli Lilly and Company (US),
• Pfizer, Inc. (US),
• Genomic Health, Inc. (US),
• bioMérieux SA (France),
• Astellas Pharma Inc. (Japan),
• Myriad Genetics (US),
• Epigenomics AG (Germany),
• Radient Pharmaceuticals (Bangladesh)
Market Definition: Global Cancer Biomarkers Market
Cancer biomarkers are the molecules secreted by a tumor or a specific response of the human body indicating the presence of cancer. The biomarkers enable cancer detection at an early stage and facilitate high-speed noninvasive diagnosis using various genomics and proteomics tools. Cancer biomarkers are used for various applications such as cancer diagnostics, drug discovery and development, prognostics, personalized medicine, and surrogate endpoints. Over the years, cancer biomarkers have become an integral part of research in pharmaceutical and clinical trial companies, as they help to reduce the time and cost of the drug discovery and development process.
According to World Health Organization, there were an estimated 9.6 million deaths in 2018 due to cancer; Cancer is the second leading cause of death globally. About 1 in 6 deaths is due to cancer. These deaths could have been avoided with the availability of proper medical equipment and devices for healthcare procedures. This significant number is expected to act as a driver to the market growth
Market Drivers
• Rising incidence of cancer is working as a market driver for this market
• Increasing use of cancer biomarkers in drug discovery and development due to its ease of use and accurate results.
• Due to increase in cancer cases there is increase in demand for Biomarkers
Market Restraints
• Unfavorable regulatory and reimbursement scenario due to high cancer case regulatory has made strict norms.
• High capital investment is required for biomarker but benefit is low as compared to cost
• Technical issues is very high at the time of sample collection and storage this is working as a market restraint.
Inquiry Before Buying @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-cancer-biomarkers-market
Segmentation: Global Cancer Biomarkers Market
By Type
o Genetic Biomarkers
o Protein Biomarkers
o Other Cancer Biomarkers
By Cancer Type
o Breast Cancer
o Lung Cancer
o Prostate Cancer
o Colorectal Cancer
o Blood Cancer
o Melanoma
o Ovarian Cancer
o Liver Cancer
o Stomach Cancer
o Other Cancer Types
By Technology
o Imaging technologies
o Omic Technologies
Proteomics
Genomics
Other Omic technologies
o Cytogenetics-Based Tests
o Immunoassays
By Applications
o Drug discovery and Development
o Personalized medicine
o Diagnostics
o Others
By Geography
o North America
o South America
o Europe
o Asia-Pacific
o Middle East & Africa
Key Developments in the Market:
• In April 2019, the University of Otago, New Zealand, and the Indian Statistical Institute (ISI), India have discovered epigenetic markers that aredistinctly different in oral cancer tissues This phenomenon is new and focused on oral cancer particularly.
• In April 2019, Princess Margaret Cancer Centre in Toronto, Canada, has combined liquid biopsy, epigenetic alterations and machine learning to develop a blood test to detect and classify cancer at its earliest stages. This will change the usage of Biomarkers in cancer Market so that cancer can be identified in its initial stages.
Competitive Analysis: Global Cancer Biomarkers Market
Global cancer biomarkers market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of cancer biomarkers market for Global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Reasons to Purchase this Report
• Current and future of Global cancer biomarkers market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
• Regions/Countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
TABLE OF CONTENTS GLOBAL CANCER BIOMARKERS MARKET
1. INTRODUCTION
1.1. OVERVIEW OF THE GLOBAL CANCER BIOMARKERS MARKET
1.2. CURRENCY AND PRICING
1.3. LIMITATION
1.4. MARKETS COVERED
2 MARKET SEGMENTATION
2.1. KEY TAKEAWAYS
2.2. ARRIVING AT THE GLOBAL CANCER BIOMARKERS MARKET SIZE
2.3. GLOBAL CANCER BIOMARKERS MARKET: RESEARCH SNAPSHOT
2.4. ASSUMPTIONS
3 MARKET OVERVIEW
3.1. DRIVERS
3.2. RESTRAINTS
3.3. OPPORTUNITIES
3.4. CHALLENGES
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
5.1. VENDOR POSITIONING GRID AND INVESTMENT OPPURTUNITIES
5.2. TECHNOLOLGICAL ADVANCEMENTS
5.3. EMPIDEMIOLOGY OF VARIOUS TYPES OF CANCER
5.4. INSIGHTS ON TECHNOLOGICAL DEVELOPMENTS IN THE GLOBAL CANCER BIOMARKERS MARKET
5.5. MARKET REGULATORY SCENARIO BY COUNTRY
5.6. INTERVIEW KEY INSIGHTS
6 GLOBAL CANCER BIOMARKERS MARKET, BY TYPE
6.1. OVERVIEW
6.2. PROTEIN BIOMARKERS
6.3. GENETIC BIOMARKERS
6.4. OTHERS
7 GLOBAL CANCER BIOMARKERS MARKET, BY CANCER TYPE
7.1. OVERVIEW
7.2. BREAST CANCER
7.3. LUNG CANCER
7.4. COLORECTAL CANCER
7.5. PROSTRATE CANCER
7.6. CERVICAL CANCER
7.7. BLOOD CANCER
7.8. OTHERS
8 GLOBAL CANCER BIOMARKERS MARKET, BY CATEGORY
8.1. OVERVIEW
8.2. CANCER BIOMARKERS OF EXPOSURE
8.3. CANCER BIOMARKERS OF DISEASE
9 GLOBAL CANCER BIOMARKERS MARKET, BY BIOMOLECULE
10 GLOBAL CANCER BIOMARKERS MARKET, BY APPLICATION
11 GLOBAL CANCER BIOMARKERS MARKET, BY TECHNOLOGY
12 GLOBAL CANCER BIOMARKERS MARKET, BY END-USER
13 GLOBAL CANCER BIOMARKERS MARKET, BY GEOGRAPHY
15 GLOBAL CANCER BIOMARKERS MARKET: COMPETITIVE LANDSCAPE
16 GLOBAL CANCER BIOMARKERS MARKET, COMPANY PROFILES
16.1 ABBOTT
16.2 BITRON HEALTHCARE
16.3 ILLUMINA, INC.
16.4 QIAGEN
16.5 F. HOFFMANN-LA ROCHE LTD
16.6 AGILENT TECHNOLOGIES
16.7 QUEST DIAGNOSTICS INC.
16.8 MERCK & CO. INC.
16.9 HOLOGIC, INC.
16.10 BD
16.11 SINO BIOLOGICAL INC.
16.12 THERMO FISHER SCIENTIFIC INC.
16.13 BIOMÉRIEUX SA
16.14 NOVARTIS AG
16.15 MYRIAD GENETICS
16.16 GENOMIC HEALTH
16.17 PFIZER, INC.
16.18 BRISTOL-MYERS SQUIBB
16.19 EPIGENOMICS AG
16.20 STAT BIOMEDICAL CO., LTD.
Request for Detailed TOC @ https://databridgemarketresearch.com/toc/?dbmr=global-cancer-biomarkers-market
About Us:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.
Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.
Contact:
Data Bridge Market Research
Tel: +1-888-387-2818
Email: sopan.gedam@databridgemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cancer Biomarkers Market Rise at a CAGR of 12.5% With Key Players Abbott, DiagnoCure, Affymetrix, Illumina, QIAGEN, F. Hoffmann-La Roche, Agilent Technologies, Quest Diagnostics, Merck & Co, Hologic, BD here
News-ID: 1731838 • Views: …
More Releases from Data Bridge Market Research
Ophthalmic Ultrasound Imaging Systems Market Size, Share, Trends, Key Drivers, G …
Global Ophthalmic Ultrasound Imaging Systems Market' the new research report adds in Data Bridge Market Research's reports database. This Research Report spread across 329 Page, 53 No of Tables, And 244 No of Figures with summarizing Top companies, with tables and figures. The Ophthalmic Ultrasound Imaging Systems market research report presents a comprehensive study on production capacity, consumption, import and export for all the major regions across the world. By…
Smartphone Sanitizer Market Size, Share, Trends, Key Drivers, Growth and Opportu …
Smartphone Sanitizer Market report is an important manuscript for every market enthusiast, policymaker, investor, and market player. The market research and analysis conducted in this report assists clients in forecasting the investment in an emerging market, growth of market share or success of a new product. In addition, this business report endows with a delegate overview of the market where it identifies industry trends, determines brand awareness, potency and insights…
Chemical Dust Suppressants Market Size, Share, Trends, Key Drivers, Growth and O …
Chemical Dust Suppressants Market research report has been prepared with the systematic gathering and evaluation of market information for industry which is presented in a form that explains various facts and figures to the business. Report saves valuable time as well as adds credibility to the work that is performed to grow business. This quality report has been planned with full commitment and transparency in research and analysis. With…
Farm Video Surveillance System Market Size, Share, Trends, Demand, Growth and Co …
Global Farm Video Surveillance System Market study by Data Bridge Market Research provides details about the market dynamics affecting the Farm Video Surveillance System market, Market scope, Market segmentation and overlays shadow upon the leading market players highlighting the favourable competitive landscape and trends prevailing over the years. Farm Video Surveillance System market analysis report is the high quality report having in-depth market research studies.
For dominating the market or industry…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
Oncology Nutrition Market led to an unprecedented rise by 2025 : liver cancer, p …
Global Oncology Nutrition Market: Overview
Cancer diagnosis creates myriad questions about diet and nutrition. Those pertain to if the food will make a patient feel sick to what should be ingested to fight cancer. This has spawned the oncology nutrition market which has been rising steadily due to the increasing cases of different types of cancer worldwide. During cancer treatment one needs to eat right in order to build up strength…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, C …
Researchmoz added Most up-to-date research on "Cancer Diagnostics Global Market: By Application - Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma & Other Cancers" to its huge collection of research reports.
This report studies Cancer Diagnostics in Global market, especially in North America, China, Europe, Southeast Asia, Japan and India, with production, revenue, consumption, import and export in these regions, from 2012 to 2016, and forecast to 2022.
This report focuses on top…
